Evan Feinberg, founder and CEO at Genesis Therapeutics, talks about using AI in drug discovery and the collaboration between ML, biotech, and chemistry. They discuss how physics-based models can improve drug design, integrating human intuition and predictive AI models, and the importance of a multidisciplinary team in drug discovery programs.